CD8+ regulatory T cells-A distinct T-cell lineage or a transient T-cell phenotype?

Human Immunology

Volumn 69, Issue 11, 2008, Pages 696-699

  Aandahl, Einar Martin ^a,b   Torgersen, Knut Martin ^a   Taskén, Kjetil ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR NFAT;

ALLERGIC ENCEPHALOMYELITIS; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL LINEAGE; CELLULAR IMMUNITY; DENDRITIC CELL; ENTERITIS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; HOMEOSTASIS; HUMANS; NEOPLASMS; PHENOTYPE; SELF TOLERANCE; T-LYMPHOCYTE SUBSETS; VIRUS DISEASES;

EID: 57649099846     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.08.291     Document Type: Article

References (74)

1. Gershon R.K., and Kondo K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 18 (1970) 723-737
2. Kilshaw P.J., Brent L., and Pinto M. Suppressor T cells in mice made unresponsive to skin allografts. Nature 255 (1975) 489-491
3. + regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22 (2004) 531-562
4. Belkaid Y., and Rouse B.T. Natural regulatory T cells in infectious disease. Nat Immunol 6 (2005) 353-360
5. Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 5 (2005) 263-274
6. Chen Y., Kuchroo V.K., Inobe J., Hafler D.A., and Weiner H.L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265 (1994) 1237-1240
7. + T cell subset that inhibits this autoimmune potential. J Exp Med 177 (1993) 627-636
8. + T cells. Immunity 1 (1994) 553-562
9. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155 (1995) 1151-1164
10. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389 (1997) 737-742
11. Zheng Y., and Rudensky A.Y. Foxp3 in control of the regulatory T cell lineage. Nat Immunol 8 (2007) 457-462
12. + regulatory T cells. Nat Immunol 4 (2003) 330-336
13. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
14. Lopes J.E., Torgerson T.R., Schubert L.A., Anover S.D., Ocheltree E.L., Ochs H.D., et al. Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor. J Immunol 177 (2006) 3133-3142
15. Wu Y., Borde M., Heissmeyer V., Feuerer M., Lapan A.D., Stroud J.C., et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126 (2006) 375-387
16. + regulatory T cells in the maintenance of T cell homeostasis. J Exp Med 200 (2004) 1123-1134
17. Xystrakis E., Cavailles P., Dejean A.S., Cautain B., Colacios C., Lagrange D., et al. Functional and genetic analysis of two CD8 T cell subsets defined by the level of CD45RC expression in the rat. J Immunol 173 (2004) 3140-3147
18. Xystrakis E., Dejean A.S., Bernard I., Druet P., Liblau R., Gonzalez-Dunia D., et al. Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation. Blood 104 (2004) 3294-3301
19. + regulatory thymocytes. Blood 102 (2003) 4107-4114
20. + regulatory thymocytes because of their responsiveness to different cytokines. Blood 103 (2004) 3117-3121
21. Fontenot J.D., Dooley J.L., Farr A.G., and Rudensky A.Y. Developmental regulation of Foxp3 expression during ontogeny. J Exp Med 202 (2005) 901-906
22. + regulatory T cells in vivo. J Exp Med 198 (2003) 249-258
23. Haribhai D., Lin W., Relland L.M., Truong N., Williams C.B., and Chatila T.A. Regulatory T cells dynamically control the primary immune response to foreign antigen. J Immunol 178 (2007) 2961-2972
24. McGuirk P., McCann C., and Mills K.H. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J Exp Med 195 (2002) 221-231
25. Apostolou I., and von Boehmer H. In vivo instruction of suppressor commitment in naive T cells. J Exp Med 199 (2004) 1401-1408
26. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198 (2003) 1875-1886
27. Kretschmer K., Apostolou I., Hawiger D., Khazaie K., Nussenzweig M.C., and von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6 (2005) 1219-1227
28. + regulatory T cells from human peripheral blood. J Immunol 166 (2001) 7282-7289
29. + regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol 78 (2004) 2454-2459
30. Knoechel B., Lohr J., Kahn E., Bluestone J.A., and Abbas A.K. Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen. J Exp Med 202 (2005) 1375-1386
31. + adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism. J Immunol 177 (2006) 246-254
32. +CD25- T cells. J Clin Invest 112 (2003) 1437-1443
33. +CD25- cells. Proc Natl Acad Sci USA 102 (2005) 4103-4108
34. + regulatory T cells by continuous antigen stimulation. J Leukocyte Biol 83 (2008) 1111-1117
35. +) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192 (2000) 1213-1222
36. Pillai V., Ortega S.B., Wang C.K., and Karandikar N.J. Transient regulatory T-cells: a state attained by all activated human T-cells. Clin Immunol 123 (2007) 18-29
37. + T cells. Eur J Immunol 37 (2007) 129-138
38. Allan S.E., Crome S.Q., Crellin N.K., Passerini L., Steiner T.S., Bacchetta R., et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 19 (2007) 345-354
39. +FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 110 (2007) 2983-2990
40. Shevach E.M. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 25 (2006) 195-201
41. Pillai V., and Karandikar N.J. Human regulatory T cells: a unique, stable thymic subset or a reversible peripheral state of differentiation?. Immunol Lett 114 (2007) 9-15
42. Selvaraj R.K., and Geiger T.L. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta. J Immunol 178 (2007) 7667-7772
43. + suppressor T cells. J Clin Invest 114 (2004) 1218-1221
44. - T cells and inhibit both T-cell proliferation and CTL function. Hum Immunol 65 (2004) 142-156
45. + Tregs. J Clin Invest 115 (2005) 2904-2913
46. Gilliet M., and Liu Y.J. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 195 (2002) 695-704
47. +) regulatory T cells by continuous antigen stimulation. Eur J Immunol 38 (2008) 640-646
48. Vlad G., Cortesini R., and Suciu-Foca N. License to heal: bidirectional interaction of antigen-specific regulatory T cells and tolerogenic APC. J Immunol 174 (2005) 5907-5914
49. + regulatory T cells in human ovarian carcinoma. Cancer Res 65 (2005) 5020-5026
50. Kumar V. Homeostatic control of immunity by TCR peptide-specific Tregs. J Clin Invest 114 (2004) 1222-1226
51. + tolerogenic endothelial cells, inhibiting alloreactivity. Int Immunol 16 (2004) 1055-1068
52. + CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers. J Immunol 179 (2007) 4323-4334
53. + regulatory T cells mediate immunosuppression in prostate cancer. Clin Cancer Res 13 (2007) 6947-6958
54. Chang C.C., Ciubotariu R., Manavalan J.S., Yuan J., Colovai A.I., Piazza F., et al. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 3 (2002) 237-243
55. +. Int Immunol 10 (1998) 775-783
56. Suciu-Foca N., Manavalan J.S., Scotto L., Kim-Schulze S., Galluzzo S., Naiyer A.J., et al. Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: review. Int Immunopharmacol 5 (2005) 7-11
57. + T cells with a regulatory phenotype and function. Eur J Immunol 35 (2005) 2896-2908
58. + T cell responses to glutamic acid decarboxylase 65. Eur J Immunol 37 (2007) 78-86
59. + regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4. Proc Natl Acad Sci USA 104 (2007) 8029-8034
60. Yamanouchi J., Rainbow D., Serra P., Howlett S., Hunter K., Garner V.E., et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet 39 (2007) 329-337
61. Yamaguchi T., Hirota K., Nagahama K., Ohkawa K., Takahashi T., Nomura T., et al. Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity 27 (2007) 145-159
62. + T cells in murine experimental allergic encephalomyelitis. Science 256 (1992) 1213-1215
63. + regulatory T cells in multiple sclerosis. J Neuroimmunol 195 (2008) 121-134
64. +CD28 regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligand. Proc Natl Acad Sci USA 104 (2007) 17459-17464
65. +CD28- regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice. Gastroenterology 131 (2006) 1775-1785
66. Belkaid Y., Mendez S., Lira R., Kadambi N., Milon G., and Sacks D. A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity. J Immunol 165 (2000) 969-977
67. + regulatory T cells control Leishmania major persistence and immunity. Nature 420 (2002) 502-507
68. +) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med 200 (2004) 331-343
69. + regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 104 (2004) 3249-3256
70. + T cell responses. J Exp Med 198 (2003) 889-901
71. + helper T cell responses in cancer patients. Blood 106 (2005) 1008-1011
72. + regulatory T cells. J Immunol 177 (2006) 896-904
73. +CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. Hum Immunol 67 (2006) 1-12
74. Yaqub S., Henjum K., Mahic M., Jahnsen F.L., Aandahl E.M., Bjornbeth B.A., et al. Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner. Cancer Immunol Immunother 57 (2008) 813-821